Report Content
Chapter 1 Methodology & Scope
1.1 Market definitions
1.2 Base estimates & working
1.2.1 Data collection
1.3 Forecast calculations
1.4 COVID-19 impact analysis at global level
1.5 Data validation
1.6 Data sources
1.6.1 Primary
1.6.2 Secondary
1.6.2.1 Paid sources
1.6.2.2 Unpaid sources
Chapter 2 Executive Summary
2.1 Zika virus testing industry 3600 synopsis, 2018 - 2032 (USD Million)
2.2 Business trends
2.3 Regional trends
2.4 Test type trends
2.5 End user trends
Chapter 3 Zika Virus Testing Industry Insights
3.1 Industry ecosystem analysis
3.2 Industry impact forces
3.2.1 Growth drivers
3.2.1.1 Growing prevalence of zika virus infection
3.2.1.2 Increasing R&D by biopharmaceutical companies
3.2.1.3 Technological advancements
3.2.1.4 Government initiatives to generate awareness regarding zika virus
3.2.2 Industry pitfalls & challenges
3.2.2.1 Excessive cost of testing Kits
3.2.2.2 Lack of reimbursement scenario
3.3 Growth potential analysis
3.3.1 By test type
3.3.2 By end user
3.4 COVID-19 impact analysis
3.5 Technology landscape
3.6 Regulatory landscape
3.6.1 U.S.
3.6.2 Europe
3.7 Porter's analysis
3.8 PESTEL analysis
Chapter 4 Competitive landscape, 2022
4.1 Introduction
4.2 Company matrix analysis, 2022
4.3 Competitive dashboard, 2022
4.4 Company market share analysis, 2022
4.5 Competitive analysis of major market players
4.6 Competitive positioning matrix
4.7 Strategic outlook matrix
Chapter 5 Zika Virus Testing Market Size and Forecast, By Test Type (USD Million)
5.1 Key trends, by test type
5.2 Serological Tests
5.2.1 Enzyme-linked immune sorbent assay (ELISA)
5.2.2 Plaque reduction and neutralization test (PRNT)
5.3 Molecular Tests
5.3.1 Reverse transcription polymerase chain reaction (RT-PCR)
5.3.2 Nucleic acid amplification testing (NAAT)
Chapter 6 Zika Virus Testing Market Size and Forecast, By End User (USD Million)
6.1 Key trends, by end user
6.2 Hospitals
6.3 Diagnostic centers
6.4 Public health laboratory
6.5 Others
Chapter 7 Zika Virus Testing Market Size and Forecast, By Region (USD Million)
7.1 Key trends, by region
7.2 North America
7.2.1 U.S.
7.2.2 Canada
7.3 Europe
7.3.1 Germany
7.3.2 UK
7.3.3 France
7.3.4 Spain
7.3.5 Italy
7.3.6 Belgium
7.3.7 The Netherlands
7.4 Asia Pacific
7.4.1 China
7.4.2 Japan
7.4.3 India
7.4.4 Australia
7.4.5 South Korea
7.4.6 Thailand
7.4.7 Singapore
7.4.8 Vietnam
7.5 Latin America
7.5.1 Brazil
7.5.2 Mexico
7.5.3 Argentina
7.5.4 Colombia
7.6 Middle East & Africa
7.6.1 South Africa
7.6.2 Saudi Arabia
7.6.3 UAE
7.6.4 Turkey
Chapter 8 Company Profiles
8.1 Abbott Laboratories
8.2 Altona Diagnostics GmbH
8.3 ChemBio Diagnostics, Inc.
8.4 ELITechGroup
8.5 F. Hoffmann-La Roche Ltd.
8.6 Genekam
8.7 DiaSorin (Luminex Corporation)
8.8 Novacyt Group
8.9 Quest Diagnostics
8.10 Siemens Healthcare GmbH
8.11 LGC Limited (SeraCare Life Sciences)
8.12 Co-Diagnostics, Inc.
8.13 Mediven (Medical Innovation Ventures )
8.14 Biocan Diagnostics, Inc.
8.15 Euroimmun
